Entity Details

Primary name SC5A7_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9GZV3
EntryNameSC5A7_HUMAN
FullNameHigh affinity choline transporter 1
TaxID9606
Evidenceevidence at protein level
Length580
SequenceStatuscomplete
DateCreated2004-12-07
DateModified2021-06-02

Ontological Relatives

GenesSLC5A7

GO terms

Show/Hide Table
GOName
GO:0001701 in utero embryonic development
GO:0005307 choline:sodium symporter activity
GO:0005886 plasma membrane
GO:0006836 neurotransmitter transport
GO:0007271 synaptic transmission, cholinergic
GO:0007274 neuromuscular synaptic transmission
GO:0008292 acetylcholine biosynthetic process
GO:0015220 choline transmembrane transporter activity
GO:0015871 choline transport
GO:0016021 integral component of membrane
GO:0030424 axon
GO:0030425 dendrite
GO:0031594 neuromuscular junction
GO:0033265 choline binding
GO:0043204 perikaryon
GO:0045202 synapse
GO:0055085 transmembrane transport

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction
Cell membrane
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001734 Sodium/solute symporterFamilyFamily
IPR038377 Sodium/glucose symporter superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
158580 OMIMNeuronopathy, distal hereditary motor, 7A (HMN7A)A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. HMN7A is characterized by onset in the second decade of progressive distal muscle wasting and weakness affecting the upper and lower limbs and resulting in walking difficulties and hand grip. There is significant muscle atrophy of the hands and lower limbs. The disorder is associated with vocal cord paresis due to involvement of the tenth cranial nerve. The disease is caused by variants affecting the gene represented in this entry.
617143 OMIMMyasthenic syndrome, congenital, 20, presynaptic (CMS20)A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness. CMS20 is an autosomal recessive, pre-synaptic form characterized by severe hypotonia and episodic apnea soon after birth, generalized limb fatigability and weakness, delayed walking, ptosis, poor sucking and swallowing. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00122 CholineDrugbanksmall molecule
DB14006 Choline salicylateDrugbanksmall molecule

Interactions

3 interactions

InteractorPartnerSourcesPublicationsLink
SC5A7_HUMANS14L1_HUMANBioGRID17092608 details
SC5A7_HUMANPAWR_HUMANBioGRID, HPRD15090548 details
SC5A7_HUMANNEDD4_HUMANBioGRID22361880 details